[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Mr. David L. Hallal", "age": 58, "title": "CEO & Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 175732, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mo  Qatanani Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 704681, "exercisedValue": 0, "unexercisedValue": 3032789}, {"maxAge": 1, "name": "Dr. Akshay K. Vaishnaw M.D., Ph.D.", "age": 61, "title": "President of R&D, Member of Scientific Advisory Board and Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 56140, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 755185, "exercisedValue": 0, "unexercisedValue": 673489}, {"maxAge": 1, "name": "Mr. Vikas  Sinha C.A., CPA, M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Keith Woods", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin  Moore CPA", "age": 49, "title": "Interim Principal Financial & Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rushmie  Nofsinger", "title": "Vice President of Corporate Affairs & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Junlin  Ho J.D.", "age": 45, "title": "General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 563729, "exercisedValue": 0, "unexercisedValue": 112564}, {"maxAge": 1, "name": "Ms. Caryn  Parlavecchio", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 45.86, "open": 45.47, "dayLow": 45.125, "dayHigh": 46.055, "regularMarketPreviousClose": 45.86, "regularMarketOpen": 45.47, "regularMarketDayLow": 45.125, "regularMarketDayHigh": 46.055, "payoutRatio": 0.0, "beta": 0.62, "forwardPE": -15.185773, "volume": 478403, "regularMarketVolume": 478403, "averageVolume": 2216047, "averageVolume10days": 1175600, "averageDailyVolume10Day": 1175600, "bid": 43.5, "ask": 54.6, "bidSize": 1, "askSize": 2, "marketCap": 4658680320, "fiftyTwoWeekLow": 22.71, "fiftyTwoWeekHigh": 48.28, "allTimeHigh": 70.0, "allTimeLow": 4.325, "fiftyDayAverage": 37.2623, "twoHundredDayAverage": 34.44025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4399126528, "profitMargins": 0.0, "floatShares": 84919168, "sharesOutstanding": 102007457, "sharesShort": 16646564, "sharesShortPriorMonth": 17166122, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.16319999, "heldPercentInsiders": 0.03757, "heldPercentInstitutions": 1.1910601, "shortRatio": 9.09, "shortPercentOfFloat": 0.274, "impliedSharesOutstanding": 102007457, "bookValue": 2.47, "priceToBook": 18.489878, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -353428000, "trailingEps": -3.15, "forwardEps": -3.00742, "enterpriseToEbitda": -12.204, "52WeekChange": 0.06432068, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 45.67, "targetHighPrice": 53.0, "targetLowPrice": 42.0, "targetMeanPrice": 47.91667, "targetMedianPrice": 48.5, "recommendationMean": 1.21429, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 12, "totalCash": 369630016, "totalCashPerShare": 3.624, "ebitda": -360478016, "totalDebt": 110076000, "quickRatio": 6.022, "currentRatio": 6.305, "debtToEquity": 44.93, "returnOnAssets": -0.76607, "returnOnEquity": -2.18037, "grossProfits": -211930000, "freeCashflow": -146885376, "operatingCashflow": -274052000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "postMarketChangePercent": 0.0, "postMarketPrice": 45.67, "postMarketChange": 0.0, "regularMarketChange": -0.190002, "regularMarketDayRange": "45.125 - 46.055", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2216047, "fiftyTwoWeekLowChange": 22.96, "fiftyTwoWeekLowChangePercent": 1.0110084, "fiftyTwoWeekRange": "22.71 - 48.28", "fiftyTwoWeekHighChange": -2.6100006, "fiftyTwoWeekHighChangePercent": -0.054059666, "fiftyTwoWeekChangePercent": 6.4320683, "earningsTimestamp": 1763127000, "earningsTimestampStart": 1763127000, "earningsTimestampEnd": 1763127000, "earningsCallTimestampStart": 1763125200, "earningsCallTimestampEnd": 1763125200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.15, "epsForward": -3.00742, "epsCurrentYear": -3.38171, "priceEpsCurrentYear": -13.505001, "fiftyDayAverageChange": 8.4077, "fiftyDayAverageChangePercent": 0.22563556, "twoHundredDayAverageChange": 11.229748, "twoHundredDayAverageChangePercent": 0.32606465, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "regularMarketChangePercent": -0.41431, "regularMarketPrice": 45.67, "corporateActions": [], "postMarketTime": 1766787850, "regularMarketTime": 1766782800, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]